Lingmin N. Zhang

Guangzhou Municipal And Guangdong Provincial Key Laboratory Of Molecular Target & Clinical Pharmacology, The NMPA And State Key Laboratory Of Respiratory Disease
Guangzhou, 511436, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Acidic-responsive nano liposomes potentiate in situ dual immunotherapy on lung cancer by codelivering antagonistic peptide and agonist.

Acidic-responsive nano liposomes potentiate in situ dual immunotherapy on lung cancer by codelivering antagonistic peptide and agonist.

Journal: International journal of pharmaceutics: X

Published: March 02, 2026

Biomineralized outer membrane vesicles for synergistic immuno-photodynamic therapy of oral squamous cell carcinoma.

Biomineralized outer membrane vesicles for synergistic immuno-photodynamic therapy of oral squamous cell carcinoma.

Journal: International journal of pharmaceutics: X

Published: February 08, 2026

The Emerging Role of Nanocarrier-Based Delivery Systems for cGAS-STING Activation in Cancer Immunotherapy.

The Emerging Role of Nanocarrier-Based Delivery Systems for cGAS-STING Activation in Cancer Immunotherapy.

Journal: International journal of nanomedicine

Published: January 22, 2026

Correction: "Two birds with one stone" strategy for the lung cancer therapy with bioinspired AIE aggregates.

Correction: "Two birds with one stone" strategy for the lung cancer therapy with bioinspired AIE aggregates.

Journal: Journal of nanobiotechnology

Published: January 20, 2026

Surface curvature-directed in situ synthesis of ultrathin 2D MOFs on liquid metals for antibacterial applications.

Surface curvature-directed in situ synthesis of ultrathin 2D MOFs on liquid metals for antibacterial applications.

Journal: Chemical science

Published: December 18, 2025

A breakthrough in NSCLC therapy: targeted protein degradation of CD26 via PROTACs.

A breakthrough in NSCLC therapy: targeted protein degradation of CD26 via PROTACs.

Journal: EBioMedicine

Published: December 04, 2025

A spatiotemporally coordinated curcumin-based microneedle patch for SDF-1α delivery and synergistic myocardial infarction therapy.

A spatiotemporally coordinated curcumin-based microneedle patch for SDF-1α delivery and synergistic myocardial infarction therapy.

Journal: Journal of nanobiotechnology

Published: November 11, 2025

Revolutionizing protein degradation: Harnessing nanoparticles for PROTAC delivery.

Revolutionizing protein degradation: Harnessing nanoparticles for PROTAC delivery.

Journal: Materials today. Bio

Published: September 24, 2025

The novel strategy to overcome the drug-resistant lung cancer: Dual targeting delivery of PROTAC to inhibit cancer-associated fibroblasts and lung cancer cells.

The novel strategy to overcome the drug-resistant lung cancer: Dual targeting delivery of PROTAC to inhibit cancer-associated fibroblasts and lung cancer cells.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: September 22, 2025

Differential transcriptomic modulation by histone deacetylase inhibitor SAHA in LUAD and LUSC.

Differential transcriptomic modulation by histone deacetylase inhibitor SAHA in LUAD and LUSC.

Journal: Clinical epigenetics

Published: August 08, 2025

In situ reprogramming of tumor associated macrophages with versatile nano-epigenetic inhibitor for lung cancer therapy.

In situ reprogramming of tumor associated macrophages with versatile nano-epigenetic inhibitor for lung cancer therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: July 08, 2025

Liver-targeted siRNA delivery via artificial red blood cells to lower LDL-C.

Liver-targeted siRNA delivery via artificial red blood cells to lower LDL-C.

Journal: International journal of pharmaceutics

Published: July 04, 2025

Showing 1-12 of 62

Last Updated: 09/26/2026